It is well documented that manipulating glucocorticoid action in adipose tissue can have systemic effects on metabolic parameters, for example, mice over-expressing 11β-HSD1 in adipose tissue have glucose intolerance but unlike Cbr1 over-expressors, they also demonstrate increased fat mass and free fatty acids [3]. Here, CBR1 is linked to Glucose intolerance.